Pharmacology for Nurses · Introduction to the Nervous System
Structure and Function of the Nervous System
On this page 9 sections
In 30 seconds
The previous topic introduced the nervous system as a communication network. This one goes deeper: neuron parts, the Action potential The electrical spike that travels down an axon Full entry → down axons, synaptic transmission across gaps, and how the CNS, PNS, somatic, and autonomic systems are organized.
For pharmacology this detail is not optional: the action potential explains why sodium-channel blockers (local anesthetics, some anticonvulsants) dampen signaling; the neurotransmitter lifecycle explains why drugs that block breakdown or reuptake amplify signaling; and the autonomic map — which nerves use acetylcholine and which norepinephrine, and which receptors they hit — explains the effects of a huge fraction of everyday drugs, from blood-pressure medicines to allergy pills.
Why this matters
- The autonomic map lets you predict side effects: a drug that stimulates one branch usually suppresses the other — sympathetic tone can raise heart rate and dilate pupils together.
- Myelin and the action potential explain real presentations: demyelination slows conduction (multiple sclerosis); sodium-channel blockade explains local anesthetics and anticonvulsants.
- Exams love the autonomic map — "Which neurotransmitter acts at the postganglionic sympathetic junction?" is a classic.
The college version
Core Concepts
Anatomy of a Neuron
A neuron has four functional zones: dendrites (branched receivers), the cell body (soma) (integrates signals), the axon (a long fiber conducting the outgoing signal), and axon terminals (endings that release neurotransmitter into the synapse). Many axons are wrapped in myelin, fatty insulation made by oligodendrocytes (CNS) and Schwann cells (PNS), interrupted at nodes of Ranvier; the signal jumps node to node — saltatory conduction — far faster than continuous conduction. Myelin loss in multiple sclerosis therefore slows or blocks signaling, producing widespread symptoms.
The Action Potential: How the Electrical Signal Works
Neurons maintain a resting membrane potential near −70 mV (inside negative), thanks largely to the sodium-potassium pump. When a stimulus depolarizes past threshold, voltage-gated sodium channels open, sodium rushes in, and the potential shoots toward positive — depolarization. Then sodium channels inactivate and voltage-gated potassium channels open; potassium leaves, restoring negativity — repolarization. During the refractory period the neuron cannot fire again immediately, keeping signals one-directional.
The action potential is all-or-none: below-threshold stimuli produce nothing; above-threshold stimuli produce the same-size spike. What varies with stimulus strength is frequency — spikes per second. Drugs that block voltage-gated sodium channels raise the threshold or prevent propagation — how local anesthetics dampen pain and anticonvulsants reduce seizures.
Synaptic Transmission: From Electrical to Chemical
At the axon terminal, the electrical signal triggers neurotransmitter release through a five-step lifecycle: synthesis (built from precursors), storage (packed into vesicles), release (calcium entry fuses vesicles with the membrane), receptor binding (opens channels or starts cascades on the next cell), and termination — via reuptake (transporters pump the chemical back in), enzymatic degradation (acetylcholinesterase breaks down ACh; MAO and COMT break down dopamine/norepinephrine), or diffusion away.
Every step is a drug target: botulinum toxin blocks ACh release; SSRIs block serotonin reuptake; acetylcholinesterase inhibitors block degradation — the step tells you whether a drug raises or lowers the signal.
Receptors: Fast Gates and Slow Switches
Neurotransmitters act through two broad families. Ionotropic receptors (ligand-gated ion channels) open directly — fast, millisecond effects (nicotinic ACh receptor). Metabotropic receptors (G-protein–coupled) trigger slower, longer intracellular cascades (muscarinic, dopamine, most adrenergic receptors). This predicts kinetics: ionotropic drugs act quickly; metabotropic drugs act gradually and persistently.
Organization of the CNS
The CNS (brain and spinal cord) processes and integrates: the cerebrum handles conscious thought, sensation, and voluntary movement; the diencephalon (thalamus — sensory relay; hypothalamus — autonomic control, temperature, appetite) regulates; the cerebellum coordinates balance; the brainstem houses vital centers for breathing and heart rate; the spinal cord carries tracts and generates reflexes (rapid responses wired in the cord). This map matters for drugs: agents depressing the medulla's respiratory center slow breathing (opioid risk); agents on the basal ganglia's dopamine system affect movement.
Organization of the PNS: Somatic and Autonomic
The PNS has two functional divisions:
- Somatic (voluntary): motor neurons release acetylcholine at the neuromuscular junction, acting on nicotinic receptors to contract skeletal muscle. Muscle relaxants block this signal; acetylcholinesterase inhibitors amplify it.
- Autonomic (involuntary): controls organs, glands, and blood vessels through two opposing branches. Sympathetic (fight-or-flight): faster heart, dilated pupils, bronchodilation; postganglionic fibers release norepinephrine onto adrenergic receptors (alpha and beta subtypes). Parasympathetic (rest-and-digest): slows the heart, stimulates digestion and salivation, constricts pupils; its fibers release acetylcholine onto muscarinic receptors. The enteric system (the gut's own network) is often counted as a third division.
The autonomic map (memorize): in both branches, the preganglionic fiber releases ACh (nicotinic receptors on the ganglion). In the sympathetic branch, the postganglionic fiber releases norepinephrine (adrenergic receptors on the target) — except sweat glands, which use ACh. In the parasympathetic branch, the postganglionic fiber releases ACh (muscarinic receptors on the target).
What the Autonomic Map Means for Drugs
Because the branches oppose each other, drug effects follow a pattern: a sympathomimetic (adrenergic agonist) mimics fight-or-flight — faster heart, higher blood pressure, dilated pupils, dry mouth. A sympatholytic (adrenergic antagonist) blocks those effects — beta-blockers slow the heart. A parasympathomimetic (cholinergic agonist) mimics rest-and-digest — slower heart, more salivation, constricted pupils. An anticholinergic blocks muscarinic receptors, producing the classic dry-and-fast profile — dry mouth, blurred near vision, constipation, urinary retention. All examples are class-level; verify specific drugs and doses against current references and prescriber orders.
Common Confusions
| Do not confuse | With | Difference |
|---|---|---|
| Depolarization | Repolarization | Depolarization = Na⁺ in, potential rises toward positive; repolarization = K⁺ out, potential returns negative |
| Sympathetic postganglionic transmission uses ACh everywhere | Norepinephrine at most sympathetic postganglionic junctions | Sweat glands are the exception — they use ACh; a classic exam trap |
| Nicotinic and muscarinic receptors are interchangeable | Two different ACh receptor families | Nicotinic = ionotropic (ganglia, neuromuscular junction, fast); muscarinic = metabotropic (parasympathetic targets, slower) |
| Preganglionic and postganglionic fibers use the same transmitter | Different transmitters per segment | Preganglionic (both branches) = ACh; sympathetic postganglionic = norepinephrine (mostly); parasympathetic postganglionic = ACh |

Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of a neuron as a train track with stations. The electrical signal is the train, jumping between stations because the track has a fast lane (myelin) with gaps. At the end of the line, the train drops off a package — the chemical message — for the next train. Some medicines block the track (like numbing a finger), some make the package stay longer so the message gets louder, and some put a fake key in the lock.
Worked example
A person is startled — a classic sympathetic response: preganglionic fibers release acetylcholine onto nicotinic receptors at sympathetic ganglia; postganglionic fibers then release norepinephrine onto adrenergic receptors in the heart, blood vessels, and airways. Result: heart rate up, blood pressure up, pupils dilated, digestion slowed.
Now suppose the prescriber orders a beta-adrenergic antagonist (beta-blocker) for this person's high blood pressure. The nurse predicts: norepinephrine can no longer fully stimulate the heart's beta receptors, so heart rate and contractility fall and blood pressure drops. Teaching: expect a slower pulse, report dizziness or an unusually slow heart rate, and discuss exercise tolerance with the care team. The same map predicts other directions: an anticholinergic (muscarinic antagonist) produces dry mouth, blurred near vision, constipation, and urinary retention — the classic dry-and-fast profile.
Key takeaways
- Neuron zones: dendrites (receive) → soma (integrate) → axon (conduct) → terminals (release neurotransmitter).
- Action potential: resting ≈ −70 mV → threshold → Na⁺ in (depolarization) → K⁺ out (repolarization) → refractory period; all-or-none; sodium-channel blockers dampen signaling.
- Autonomic map: preganglionic = ACh (nicotinic) in both branches; sympathetic postganglionic = norepinephrine (adrenergic α/β) except sweat glands (ACh); parasympathetic postganglionic = ACh (muscarinic).
Check yourself
4 review questions from the chapter. Try each one, then open the answer.
What happens to ion flow during depolarization and repolarization, and what is the approximate resting membrane potential?
Show answer
Depolarization: sodium channels open, Na⁺ rushes in, the inside becomes less negative. Repolarization: potassium channels open, K⁺ leaves, negativity is restored. Resting potential is approximately −70 mV.
A drug blocks voltage-gated sodium channels. What effect would you predict on signaling, and what clinical use does this suggest?
Show answer
Blocking sodium channels prevents depolarization, so action potentials cannot propagate — signaling is dampened. This mechanism underlies local anesthetics (blocking pain signals) and some anticonvulsants (reducing seizure activity).
Draw (in words) the autonomic map: which neurotransmitter and receptor type at the sympathetic postganglionic junction? At the parasympathetic postganglionic junction?
Show answer
Sympathetic postganglionic: norepinephrine on adrenergic (α/β) receptors — except sweat glands, which use ACh. Parasympathetic postganglionic: acetylcholine on muscarinic receptors. (Both preganglionic segments use ACh on nicotinic receptors.)
Acetylcholinesterase breaks down acetylcholine. What would an acetylcholinesterase inhibitor do to ACh signaling, and in what disorder might it be useful (mechanism only)?
Show answer
Inhibiting acetylcholinesterase slows ACh breakdown, so ACh accumulates and signaling is amplified (stronger muscle contraction, more salivation/GI activity, slower heart). Mechanistically this is the basis of drugs used in myasthenia gravis to strengthen weak muscles — verify specific drugs and dosing against current references and prescriber orders.
Study toolsKey vocabulary
Key vocabulary
- Action potential
- The electrical spike that travels down an axon
- Ionotropic receptor
- Receptor that is itself an ion channel — fast response
- Metabotropic receptor
- G-protein–coupled receptor with slower, longer effects
- Nicotinic receptor
- ACh receptor type at ganglia and neuromuscular junction
- Muscarinic receptor
- ACh receptor type on parasympathetic target organs
- Adrenergic receptor
- Receptor for norepinephrine/epinephrine (α and β subtypes)
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

